CRSP

Conviction 45HealthcareScan · Thu, Sep 24, 2026

CRISPR Therapeutics AG (CRSP) closed at $55.74 (-0.04%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 51, RS Rating 42, -27.4% from its 52-week high, +3.7% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

CRSP$55.74-0.04%

ResistanceSupportVol 14Insider sell

Vol MA14 1.81M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

WSB mentions · 24h changelatest +100.00%· 2 mentions

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

CRISPR Therapeutics AGBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.crisprtx.com ↗

Price55.74

Change-0.04%

Gap-1.25%

Rel volume1.02×

Avg volume1.63M

Avg $ vol90.8M

SMA 2055.60

SMA 5053.49

SMA 20053.35

Price vs 50+4.21%

Price vs 200+4.48%

MA stackbullish

50/200 crossgolden · 1d

Supertrendup · 50.75

RSI (14)51

MACD hist0.14

MACD crossbull · 3d

Stoch %K / %D47 / 59

ADX (14)23

+DI / −DI24 / 18

RSI divergence—

MACD divergence—

ATR %5.23%

ADR %4.47%

52w high76.78

52w low44.34

From 52w high-27.40%

Above 52w low+25.71%

New 52w highNo

SqueezeOff

Bollinger width17.02%

%B0.51

Donchian pos46.96%

Donchian high60.72

Donchian low51.33

AVWAP (52w high)55.18

vs AVWAP high+1.01%

AVWAP (52w low)53.42

vs AVWAP low+4.34%

OBV trendDown

Chaikin MF (20)-0.12

Today vs 20d1.02×

Avg vol (14d)1.81M

Avg vol (20d)1.63M

Avg $ vol (20d)90.8M

Market cap5.39B

RS Rating42 / 99

RS 3m (vs SPY)-1.23%

RS 6m (vs SPY)+1.55%

RS line new highNo

Trend template3/8

Technical rank65.9

1 week-2.76%

1 month-8.47%

3 months+3.26%

6 months+18.37%

1 year-8.26%

YTD+3.66%

P/E-9.27

P/B3.09

P/S—

P/FCF-15.58

EPS-6.47

Div yield—

ROE-33.30%

ROA-21.94%

Debt/Eq0.34

Current17.85

EV/EBITDA-8.81

Gross margin—

Net margin—

Rev growth-90.59%

EPS growth-58.80%

Price target73.58

Target upside32.01%

Analyst ratingBuy

Institutional81.40%

Ent. value5.68B

Revenue10.18M

Net income-91.15M

Gross profit—

Free cash flow-345.93M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out96.45M

Employees393

ListedWed, Oct 19, 2016

Free float82.71M

Float %86.2%

Short interest18.77M

Days to cover10.7d

Short volume52.9%

Squeeze score74 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.94 vs −$1.10

Last surprise+14.6% beat

Setup gradeC

Conviction45 / 100

Pattern quality—

Tech rank65.9 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance61.63

Support51.57

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Aug 18
1 scan
→
Broke out
Aug 20
1 scan
→
Setting up
Aug 25
1 scan

Congress activity

Disclosed STOCK Act trades in CRSP

All disclosures →

No recent disclosed trades by Congress in CRSP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CRSP · open-market 1 sell

Insider	Side	Shares	Value	Traded	Filed
Behbahani Ali Director · Common Shares · 2026-09-17	Exercise	30K	$420K	2026-09-17	2026-09-21
Behbahani Ali Director · Common Shares · 2026-09-17	Sell	13.68K	$781K	2026-09-17	2026-09-21
Behbahani Ali Director · Stock Option (Right to Buy) · 2026-09-17	Exercise	30K	—	2026-09-17	2026-09-21
Behbahani Ali Director · Common Shares · 2025-08-06	Acquire	60	—	2025-08-06	2026-09-21
Behbahani Ali Director · Common Shares · 2025-08-06	Acquire	15	—	2025-08-06	2026-09-21
Prasad Raju Chief Financial Officer · Common Shares · 2026-08-07	Gift	750	—	2026-08-07	2026-08-11
Fleming Harold Edward Director · Stock Option (Right to Buy) · 2026-06-05	Grant	13K	$0	2026-06-05	2026-06-09
High Katherine A Director · Stock Option (Right to Buy) · 2026-06-05	Grant	13K	$0	2026-06-05	2026-06-09
Mahatme Sandesh Director · Stock Option (Right to Buy) · 2026-06-05	Grant	13K	$0	2026-06-05	2026-06-09
Fardis Maria Director · Stock Option (Right to Buy) · 2026-06-05	Grant	13K	$0	2026-06-05	2026-06-09

SEC filings

EDGAR filings in CRSP · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.